US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist

15.500
+0.870+5.95%

Close May 14 16:00 ET

668.29MMarket Cap-8801P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyverna Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Revenue(YoY)

0.00

-100.00%

EPS(YoY)

-0.51

-53.76%

Analyst Rating

Strong Buy

May 14, 2024

Kyverna Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q3	-- / 0.000	--
--	2024/Q2	-- / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q3-- / 0.000--

--2024/Q2-- / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Kyverna Therapeutics Earnings Reports

Kyverna Therapeutics | 10-Q: Quarterly report

16:35 ET

Kyverna Therapeutics | 10-K: Annual report

Mar 26 16:45 ET

Analysis

Analyst Rating

Updated: May 14, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Overall